PATEL DINESH V PH D
SEC CIK 1120477 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PTGX | Protagonist Therapeutics, Inc | Pres, CEO, Dir, 10% | 530.2K | — | $73.79M | 54 | 2021-09-21 | 2026-09-08 |
Most active insiders at PTGX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | PATEL DINESH V PH D | Pres, CEO, Dir | — | $60.58M |
| 2 | Ali Asif | CFO | — | $7.32M |
| 3 | Giraudo Bryan | Dir | — | $5.92M |
| 4 | Waddill William D. | Dir | — | $5.58M |
| 5 | MOLINA ARTURO MD | Chief Medical Off | — | $4.49M |
| 6 | SELICK HAROLD E | Dir | — | $2.52M |
| 7 | Williams Lewis T | Dir | — | $1.48M |
| 8 | O'Dowd Sarah A | Dir | — | — |
Transactions 54
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-09-10 21:17 | 2026-09-08+ | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | M - OptEx | $21.58 | +125.0K | 530.2K | +31% | +$2.70M |
| DMT | 2026-09-10 21:17 | 2026-09-08+ | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | S - Sale+OE | $145.92 | -125.0K | 523.0K | -19% | -$18.24M |
| 2026-09-08 17:14 | 2026-09-03 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | G - Gift | $0.00 | -510 | 523.0K | -0.1% | $0 | |
| DMT | 2026-08-12 18:43 | 2026-08-10+ | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | M - OptEx | $21.58 | +100.0K | 557.7K | +22% | +$2.16M |
| DMT | 2026-08-12 18:43 | 2026-08-10+ | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | S - Sale+OE | $148.91 | -100.0K | 523.5K | -16% | -$14.89M |
| DAT | 2026-05-14 20:06 | 2026-05-12 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | M - OptEx | $21.58 | +75.0K | 598.5K | +14% | +$1.62M |
| DAT | 2026-05-14 20:06 | 2026-05-12 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | S - Sale+OE | $100.12 | -75.0K | 523.5K | -13% | -$7.51M |
| D | 2026-05-12 19:28 | 2026-05-12 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | M - OptEx | $21.58 | +75.0K | 598.5K | +14% | +$1.62M |
| D | 2026-05-12 19:28 | 2026-05-12 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | S - Sale+OE | $100.12 | -75.0K | 523.5K | -13% | -$7.51M |
| 2026-04-24 16:10 | 2026-04-23 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | G - Gift | $0.00 | -1,460 | 523.5K | -0.3% | $0 | |
| DM | 2026-03-25 | 2026-03-24+ | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | M - OptEx | $8.58 | +54.7K | 579.6K | +10% | +$469.3K |
| DM | 2026-03-25 | 2026-03-24+ | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | S - Sale+OE | $101.00 | -54.7K | 524.9K | -9% | -$5.52M |
| D | 2026-03-25 | 2026-03-23 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | G - Gift | $0.00 | -50.0K | 524.9K | -9% | $0 |
| DM | 2026-01-27 | 2026-01-23+ | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | S - Sale+OE | $84.18 | -48.3K | 574.5K | -8% | -$4.06M |
| DM | 2026-01-27 | 2026-01-23+ | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | M - OptEx | $10.79 | +48.3K | 578.6K | +9% | +$520.6K |
| D | 2026-01-27 | 2026-01-23 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | G - Gift | $0.00 | -6,000 | 574.5K | -1% | $0 |
| 2026-01-21 | 2026-01-20 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | S - Sale | $82.48 | -34.4K | 580.5K | -6% | -$2.84M | |
| D | 2026-01-06 | 2026-01-02 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | A - Grant | $0.00 | +95.4K | 614.9K | +18% | $0 |
| 2025-11-24 | 2025-11-21 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | G - Gift | $0.00 | -440 | 519.5K | -0.1% | $0 | |
| 2025-09-18 | 2025-09-16 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | G - Gift | $0.00 | -620 | 520.0K | -0.1% | $0 | |
| 2025-07-28 | 2025-07-25 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | S - Sale | $54.78 | -10.4K | 520.6K | -2% | -$570.5K | |
| M | 2025-07-23 | 2025-07-21+ | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | S - Sale | $54.92 | -52.4K | 531.0K | -9% | -$2.88M |
| 2025-07-23 | 2025-07-21 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | A - Grant | $0.00 | +25.0K | 583.5K | +4% | $0 | |
| 2025-07-18 | 2025-07-16 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | G - Gift | $0.00 | -5,000 | 558.5K | -0.9% | $0 | |
| M | 2025-06-17 | 2025-06-13+ | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | G - Gift | $0.00 | -1,355 | 563.6K | -0.2% | $0 |
| D | 2025-03-05 | 2025-03-05 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | M - OptEx | $4.21 | +24.0K | 564.3K | +4% | +$101.0K |
| 2025-02-20 | 2025-02-19 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | S - Sale | $38.18 | -5,359 | 540.3K | -1.0% | -$204.6K | |
| 2025-01-17 | 2025-01-15 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | F - Tax | $0.00 | -12.6K | 545.6K | -2% | $0 | |
| D | 2025-01-06 | 2025-01-02 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | A - Grant | $0.00 | +149.8K | 558.3K | +37% | $0 |
| D | 2024-11-27 | 2024-11-25 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | M - OptEx | $21.58 | +1,727 | 429.9K | +0.4% | +$37.3K |
| DM | 2024-11-27 | 2024-11-25+ | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | S - Sale+OE | $46.81 | -100.0K | 435.2K | -19% | -$4.68M |
| D | 2024-11-27 | 2024-11-25 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | G - Gift | $0.00 | -7,000 | 428.2K | -2% | $0 |
| 2024-11-21 | 2024-11-19 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | G - Gift | $0.00 | -1,000 | 513.4K | -0.2% | $0 | |
| 2024-06-17 | 2024-06-13 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | G - Gift | $0.00 | -1,000 | 514.4K | -0.2% | $0 | |
| 2024-06-11 | 2024-06-07 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | S - Sale | $35.19 | -35.0K | 515.4K | -6% | -$1.23M | |
| 2024-04-02 | 2024-04-01 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | S - Sale | $28.31 | -25.0K | 549.6K | -4% | -$707.8K | |
| 2024-03-01 | 2024-03-01 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | S - Sale | $31.62 | -30.0K | 574.6K | -5% | -$948.6K | |
| 2024-02-28 | 2024-02-26 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | F - Tax | $29.53 | -10.9K | 604.6K | -2% | -$322.3K | |
| 2024-02-20 | 2024-02-15 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | F - Tax | $28.23 | -3,717 | 615.5K | -0.6% | -$104.9K | |
| D | 2024-01-04 | 2024-01-02 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | A - Grant | $0.00 | +84.9K | 619.2K | +16% | $0 |
| 2023-12-15 | 2023-12-13 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | S - Sale | $20.08 | -75.0K | 534.3K | -12% | -$1.51M | |
| D | 2023-10-19 | 2023-10-18 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | M - OptEx | $4.21 | +6,000 | 609.3K | +1.0% | +$25.3K |
| 2023-06-02 | 2023-02-22 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | G - Gift | $0.00 | -10.0K | 583.4K | -2% | $0 | |
| 2023-06-02 | 2023-05-31 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | F - Tax | $26.07 | -12.2K | 602.9K | -2% | -$317.1K | |
| 2023-06-02 | 2023-05-31 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | A - Grant | $0.00 | +30.0K | 615.1K | +5% | $0 | |
| DM | 2023-01-18 | 2022-05-04+ | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | G - Gift | $0.00 | -6,116 | 581.0K | -1% | $0 |
| D | 2022-08-24 | 2022-08-23 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | M - OptEx | $4.21 | +20.0K | 604.0K | +3% | +$84.2K |
| D | 2022-05-04 | 2022-05-04 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | M - OptEx | $4.21 | +15.7K | 584.0K | +3% | +$66.3K |
| D | 2022-04-26 | 2022-04-26 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | M - OptEx | $4.21 | +30.0K | 568.3K | +6% | +$126.3K |
| D | 2022-04-14 | 2022-04-14 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir, 10% | M - OptEx | $1.89 | +34.1K | 537.8K | +7% | +$64.4K |
| 2022-03-02 | 2022-02-28 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | F - Tax | $24.28 | -4,648 | 503.8K | -0.9% | -$112.9K | |
| D | 2022-02-17 | 2022-02-15 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | A - Grant | $0.00 | +31.2K | 508.4K | +7% | $0 |
| 2021-12-23 | 2021-12-21 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | S - Sale | $32.14 | -15.0K | 477.2K | -3% | -$482.1K | |
| D | 2021-09-21 | 2021-09-21 | PTGX | Protagonist Therapeutics, Inc | PATEL DINESH V PH D | Pres, CEO, Dir | M - OptEx | $4.21 | +40.0K | 492.2K | +9% | +$168.4K |
Purchase Sale Sale after option exercise All abbreviations